APA 6th Edition Včev, A., Begić, I., Ostojić, R., Jurčić, D., Božić, D., Soldo, I., ... Mićunović, N. (2006). Esomeprazole Versus Pantoprazole for Healing Erosive Oesophagitis. Collegium antropologicum, 30 (3), 519-522. Preuzeto s https://hrcak.srce.hr/27602
MLA 8th Edition Včev, Aleksandar, et al. "Esomeprazole Versus Pantoprazole for Healing Erosive Oesophagitis." Collegium antropologicum, vol. 30, br. 3, 2006, str. 519-522. https://hrcak.srce.hr/27602. Citirano 23.02.2020.
Chicago 17th Edition Včev, Aleksandar, Ivana Begić, Rajko Ostojić, Dragan Jurčić, Dubravko Božić, Ivan Soldo, Rudika Gmajnić, Goran Kondža, Eyad Khaznadar i Nikola Mićunović. "Esomeprazole Versus Pantoprazole for Healing Erosive Oesophagitis." Collegium antropologicum 30, br. 3 (2006): 519-522. https://hrcak.srce.hr/27602
Harvard Včev, A., et al. (2006). 'Esomeprazole Versus Pantoprazole for Healing Erosive Oesophagitis', Collegium antropologicum, 30(3), str. 519-522. Preuzeto s: https://hrcak.srce.hr/27602 (Datum pristupa: 23.02.2020.)
Vancouver Včev A, Begić I, Ostojić R, Jurčić D, Božić D, Soldo I i sur. Esomeprazole Versus Pantoprazole for Healing Erosive Oesophagitis. Collegium antropologicum [Internet]. 2006 [pristupljeno 23.02.2020.];30(3):519-522. Dostupno na: https://hrcak.srce.hr/27602
IEEE A. Včev, et al., "Esomeprazole Versus Pantoprazole for Healing Erosive Oesophagitis", Collegium antropologicum, vol.30, br. 3, str. 519-522, 2006. [Online]. Dostupno na: https://hrcak.srce.hr/27602. [Citirano: 23.02.2020.]
Sažetak The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to healing and relief
from gastroesophageal reflux disease-related symptoms. I this multicentre, randomized, single-blind study 180 patients
(ITT population) diagnosed with endoscopically proven GERD grade A,B,C received esomeprazole (40 mg once daily
(o.d.), n=90) or pantoprazole (40 mg o.d., n=90). Healing and relief from GERD-related symptoms were assessed at first
and final visit (after 4 or 8 weeks of treatment). Esomeprazole 40 mg provided significantly greater healing than pantoprazole
40 mg after 4 weeks of treatment in patients with EE (77.8% vs. 72.2%). Esomeprazole-treated patients were
healed after up to 8 weeks of treatment similar those treated with pantoprazole (92.2% vs. 91.1%). The proportion of
heartburn-free days was similar in patients treated with esomeprazole and to those treated with pantoprazole.